Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance. [electronic resource]
Producer: 20200612Description: 5553-5567 p. digitalISSN:- 1558-8238
- Adult
- Aged
- Aged, 80 and over
- Animals
- B7-H1 Antigen -- antagonists & inhibitors
- Endothelium -- physiology
- Female
- Galectin 1 -- antagonists & inhibitors
- Galectins -- physiology
- Head and Neck Neoplasms -- drug therapy
- Humans
- Immune Tolerance
- Immunotherapy
- Male
- Mice
- Mice, Inbred C57BL
- Middle Aged
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- STAT1 Transcription Factor -- physiology
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.